MIV eyes human implants for polymer-free DES (drug-eluting stent) technology
This article was originally published in Clinica
Executive Summary
In an effort to bring to market what it claims could be an improved drug-eluting stent (DES), MIV Therapeutics is planning to begin the first-in-man implants of its polymer-free stent coating early in 2007.